Malassezia pachydermatis is one of most frequent
aetiological agents responsible for skin disease in dogs
and, in severe infections, the disease requires long treatments
and/or high doses of antifungal agents (Bond, 2010).
Malassezia dermatitis is frequently treated with systemic
ketoconazole (KTZ) and itraconazole (ITZ) (Bond, 2010).
Nowadays, the CLSI M27-A2 method established by the
Clinical and Laboratory Standards Institute